Edwards Lifesciences (EW) Income from Continuing Operations (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Income from Continuing Operations of 380700000.0 for Q1 2026, up 4.7% year-over-year from 363600000.0 in Q1 2025, and up 492.99% quarter-over-quarter from 64200000.0 in Q4 2025.
Edwards Lifesciences (EW) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 380700000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 4.7% year-over-year to 380700000.0; the TTM figure through Mar 2026 stood at 1073100000.0 (down 25.2% YoY), while the FY2025 annual figure was 1056000000.0, down 24.36% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 380700000.0, up from 64200000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 406400000.0 in Q2 2022, with the low at 64200000.0 in Q4 2025.
- The 5-year median for Income from Continuing Operations is 340500000.0 (2023), against an average of 318788235.29.
- The sharpest annual moves came in 2023 and 2025: Income from Continuing Operations soared 66.13% in 2023, then slumped 81.39% in 2025.
- Edwards Lifesciences' Income from Continuing Operations stood at 200500000.0 in 2022, then jumped by 66.13% to 333100000.0 in 2023, then climbed by 3.57% to 345000000.0 in 2024, then plunged by 81.39% to 64200000.0 in 2025, then soared by 492.99% to 380700000.0 in 2026.
- Business Quant data shows EW's Income from Continuing Operations at 380700000.0 in Q1 2026, 64200000.0 in Q4 2025, and 292300000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.62 Bn | 126.15 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.89 Bn | 110.67 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.01 Bn | 73.47 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.48 Bn | 48.23 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.69 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.41 Bn | 23.09 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.35 Bn | 18.94 Bn | 1.54 Bn | 199.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 241.40 Mn |
| Mar 31, 2026 | 380.70 Mn |
| Dec 31, 2025 | 64.20 Mn |
| Sep 30, 2025 | 292.30 Mn |
| Jun 30, 2025 | 335.90 Mn |
| Mar 31, 2025 | 363.60 Mn |
| Dec 31, 2024 | 345.00 Mn |
| Sep 30, 2024 | 362.10 Mn |
| Jun 30, 2024 | 364.00 Mn |
| Mar 31, 2024 | 324.90 Mn |
| Dec 31, 2023 | 333.10 Mn |
| Sep 30, 2023 | 334.90 Mn |
| Jun 30, 2023 | 254.20 Mn |
| Mar 31, 2023 | 340.50 Mn |
| Dec 31, 2022 | 200.50 Mn |
| Sep 30, 2022 | 343.50 Mn |
| Jun 30, 2022 | 406.40 Mn |
| Mar 31, 2022 | 373.60 Mn |
| Dec 31, 2021 | 335.30 Mn |
| Sep 30, 2021 | 340.10 Mn |